Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Increases By 69.0%

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 607,700 shares, a growth of 69.0% from the October 15th total of 359,500 shares. Based on an average daily trading volume, of 270,200 shares, the days-to-cover ratio is presently 2.2 days.

Ascentage Pharma Group International Stock Performance

Shares of OTCMKTS:ASPHF opened at $6.45 on Thursday. The company’s 50 day moving average is $4.12 and its 200 day moving average is $3.17. Ascentage Pharma Group International has a twelve month low of $6.45 and a twelve month high of $6.45.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.